Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-23-000003

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading kros-20230106.htm…